Cargando…

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6712500/ https://www.ncbi.nlm.nih.gov/pubmed/32461716 http://dx.doi.org/10.2147/IJN.S225378

Ejemplares similares

Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex
por: Wang, Xiang, et al.
Publicado: (2019)

Codelivery of Doxorubicin and MDR1-siRNA by Mesoporous Silica Nanoparticles-Polymerpolyethylenimine to Improve Oral Squamous Carcinoma Treatment [Corrigendum]
Publicado: (2021)

siRNAdb: a database of siRNA sequences
por: Chalk, Alistair M., et al.
Publicado: (2005)

Exosome-Delivered c-Met siRNA Could Reverse Chemoresistance to Cisplatin in Gastric Cancer [Corrigendum]
Publicado: (2022)

A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites
por: Du, Quan, et al.
Publicado: (2005)

Cyclam-Modified Polyethyleneimine for Simultaneous TGFβ siRNA Delivery and CXCR4 Inhibition for the Treatment of CCl4-Induced Liver Fibrosis [Corrigendum]
Publicado: (2021)

Targeted siRNA Nanoparticles for Mammary Carcinoma Therapy
por: Ben-David-Naim, Meital, et al.
Publicado: (2019)

Corrigendum to “Data for proteomic analysis of murine cardiomyocytic HL-1 cells treated with siRNA against tissue factor” [Data Brief 3 (2015) 117–119]
por: Brioschi, Maura, et al.
Publicado: (2015)

Identification of metabolically stable 5΄-phosphate analogs that support single-stranded siRNA activity
por: Prakash, Thazha P., et al.
Publicado: (2017)

Corrigendum to: iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
Publicado: (2022)

MicroRNA-769-5p Promotes the Growth of Glioma Cells by Targeting Lysine Methyltransferase 2A [Corrigendum]
Publicado: (2021)

MicroRNA-137 has a suppressive role in liver cancer via targeting EZH2
por: Cui, Shichang, et al.
Publicado: (2018)

Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1
por: Zhou, Peizhi, et al.
Publicado: (2018)

siRNA nanoformulation against the Ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma
por: de Martimprey, Henri, et al.
Publicado: (2008)

siRNA carrying an (E)-vinylphosphonate moiety at the 5΄ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2
por: Elkayam, Elad, et al.
Publicado: (2017)

siRNA-mediated inhibition of endogenous brain-derived neurotrophic factor gene modulates the biological behavior of HeLa cells
por: Sun, Chun-Yan, et al.
Publicado: (2021)

Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA
por: Yingyuad, Peerada, et al.
Publicado: (2014)

Hypoxia-responsive ionizable liposome delivery siRNA for glioma therapy
por: Liu, Hong-Mei, et al.
Publicado: (2017)

Nanoparticle Formulations of siRNA: The Next Generation of Targeted Therapy for Lymphomas and Leukemias?
por: Wang, Andrew Z.
Publicado: (2014)

Corrigendum: Tumour‐associated macrophages as a novel target of VEGI‐251 in cancer therapy
Publicado: (2022)

Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy [Corrigendum]
Publicado: (2019)

Effect of the amount of cationic lipid used to complex siRNA on the cytotoxicity and proinflammatory activity of siRNA-solid lipid nanoparticles
por: Hanafy, Mahmoud S., et al.
Publicado: (2023)

Antitumor Effect of a New Nano-Vector with miRNA-135a on Malignant Glioma [Corrigendum]
Publicado: (2020)

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia, Yu, et al.
Publicado: (2017)

Targeted delivery of HES5-siRNA with novel polypeptide-modified nanoparticles for hepatocellular carcinoma therapy
por: Xia, Yu, et al.
Publicado: (2018)

Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)

Protection and Systemic Translocation of siRNA Following Oral Administration of Chitosan/siRNA Nanoparticles
por: Ballarín-González, Borja, et al.
Publicado: (2013)

A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19
por: Idris, Adi, et al.
Publicado: (2021)

Corrigendum to “Intraoperative Contrast Enhanced Ultrasound Evaluates the Grade of Glioma”
por: Cheng, Ling-Gang, et al.
Publicado: (2017)

CIRP Regulates BEV-Induced Cell Migration in Gliomas [Corrigendum]
Publicado: (2020)

Targeted Delivery of Doxorubicin Utilizing Chitosan Nanoparticles Surface Functionalized with Anti Her2 Trastuzumab [Corrigendum]
Publicado: (2022)

siRNA for Influenza Therapy
por: Barik, Sailen
Publicado: (2010)

Corrigendum to: Novel cancer gene discovery using a forward genetic screen in RCAS-PDGFB-driven gliomas
Publicado: (2023)

Novel targeted siRNA-loaded hybrid nanoparticles: preparation, characterization and in vitro evaluation
por: Dim, Nneka, et al.
Publicado: (2015)

Pegylated Gold Nanoparticles Conjugated with siRNA: Complexes Formation and Cytotoxicity
por: Okła, Elżbieta, et al.
Publicado: (2023)

HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
por: Qi, Yangzhi, et al.
Publicado: (2022)

Albumin pre-coating enhances intracellular siRNA delivery of multifunctional amphiphile/siRNA nanoparticles
por: Kummitha, China M, et al.
Publicado: (2012)

Folate Decorated Multifunctional Biodegradable Nanoparticles for Gastric Carcinoma Active Targeting Theranostics [Corrigendum]
Publicado: (2022)

Targeting HPV‐infected cervical cancer cells with PEGylated liposomes encapsulating siRNA and the role of siRNA complexation with polyethylenimine
por: Levine, Rachel M., et al.
Publicado: (2016)

Corrigendum to “Calcium Channel Expression and Applicability as Targeted Therapies in Melanoma”
por: Macià, A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dgjfeafs45trduc125be2i80bg